News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
343 Results
Type
Article (72)
Press Release (271)
Section
Business (151)
Deals (23)
Drug Development (71)
FDA (14)
Job Trends (26)
News (202)
Policy (33)
Tag
Academia (4)
Alliances (69)
Approvals (14)
Bankruptcy (1)
Best Places to Work (27)
Cancer (1)
Clinical research (30)
Collaboration (2)
COVID-19 (42)
Diagnostics (9)
Earnings (50)
Events (51)
FDA (14)
GLP-1 (1)
Government (17)
Healthcare (17)
Infectious disease (42)
IPO (13)
Layoffs (1)
Legal (4)
Medical device (2)
Medtech (2)
Mergers & acquisitions (9)
NextGen: Class of 2025 (7)
Non-profit (3)
People (24)
Phase I (15)
Phase II (21)
Phase III (19)
Postmarket research (1)
Preclinical (7)
Real estate (2)
Regulatory (21)
Research institute (6)
Startups (4)
United States (2)
Vaccines (1)
Date
Last 30 days (3)
Last 365 days (27)
2025 (8)
2024 (32)
2023 (41)
2022 (40)
2021 (98)
2020 (92)
2019 (14)
2018 (8)
2017 (5)
2016 (5)
Location
Asia (18)
Canada (19)
Delaware (2)
Europe (28)
343 Results for "abcellera".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AbCellera to Participate at Upcoming Investor Conferences in May and June
April 8, 2025
·
1 min read
Press Releases
AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025
April 4, 2025
·
1 min read
Press Releases
AbCellera Reports Full Year 2024 Business Results
February 27, 2025
·
12 min read
Press Releases
AbCellera to Participate at Upcoming Investor Conferences in March 2025
February 12, 2025
·
1 min read
Press Releases
AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025
March 25, 2025
·
3 min read
Press Releases
AbCellera to Report Full Year 2024 Financial Results on February 27, 2025
January 21, 2025
·
1 min read
Press Releases
AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology
January 13, 2025
·
3 min read
Business
AbCellera Reports Q1 2024 Business Results
AbCellera (Nasdaq: ABCL) today announced financial results for the first quarter of 2024.
May 7, 2024
·
12 min read
Press Releases
AbCellera to Present at Upcoming Investor Conferences in December and January
November 22, 2024
·
1 min read
Business
AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024
AbCellera (Nasdaq: ABCL) will announce its second quarter 2024 financial results on Tuesday, August 6, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.
June 25, 2024
·
1 min read
1 of 35
Next
